Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
32 hedge funds and large institutions have $4.14M invested in Nymox Pharmaceutical Corp in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 6 closing their positions.
4% more capital invested
Capital invested by funds: $3.98M → $4.14M (+$170K)
0% more funds holding
Funds holding: 32 → 32 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
26% less call options, than puts
Call options by funds: $288K | Put options by funds: $390K
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$447K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$229K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$133K |
| 4 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$107K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
+$75.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$190K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$140K |
| 3 |
Renaissance Technologies
New York
|
-$97.4K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$94K |
| 5 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$91K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFEC
26
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $16K | +$17.5K | +3,008 | New |
|
|
U
27
UBS
Zurich,
Switzerland
| $13K | -$13.8K | -2,370 | -50% |
|
28
ClearBridge Investments
New York
| $5K | – | – | – |
|
29
Creative Planning
Overland Park,
Kansas
| $5K | – | – | – |
|
30
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $4K | -$15.1K | -2,597 | -76% |
|
31
AllianceBernstein
Nashville,
Tennessee
| $1K | – | – | – |
|
32
Citigroup
New York
| $1K | +$1.04K | +179 | +542% |
|
|
33
CIBC World Market
Toronto,
Ontario, Canada
| – | -$190K | -31,372 | Closed |
|
|
VKH
34
Virtu KCG Holdings
New York
| – | -$140K | -23,325 | Closed |
|
|
GCP
35
GSA Capital Partners
London,
United Kingdom
| – | -$94K | -15,479 | Closed |
|
|
DDC
36
DF Dent & Co
Baltimore,
Maryland
| – | -$91K | -15,000 | Closed |
|
|
ASN
37
Advisory Services Network
Atlanta,
Georgia
| – | -$4K | -600 | Closed |
|
NYMX Hedge Fund Activity: Q1 2014 in Review
32 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2014, worth a combined $4.14M — up 4.3% from $3.98M a quarter earlier.
Fund positioning in NYMX was balanced in Q1 2014: 6 funds opened new positions, 6 closed out, 5 added to existing stakes and 9 trimmed.
The largest buyer was Advisors Asset Management, opening a new position worth an estimated $447K. The largest seller was CIBC World Market, exiting entirely with an estimated $190K sold.
- 32 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $4.14M of Nymox Pharmaceutical Corp stock for Q1 2014, up 4.3% quarter-over-quarter.
- 6 funds opened new Nymox Pharmaceutical Corp positions in Q1 2014 and 6 closed out, a net change of 0 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q1 2014 was Advisors Asset Management, an estimated $447K added.
- The largest Nymox Pharmaceutical Corp seller in Q1 2014 was CIBC World Market, an estimated $190K sold.
Based on aggregated 13F filings for Q1 2014.